Semi-Annual Consolidated Statement Of Income

KYORIN Pharmaceutical Co., Ltd. - Filing #7558629

Concept 2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
Semi-annual consolidated statement of income
Statement of income
Net sales
113,270,000,000 JPY
105,534,000,000 JPY
Cost of sales
63,102,000,000 JPY
56,093,000,000 JPY
Gross profit (loss)
50,167,000,000 JPY
49,441,000,000 JPY
Ordinary profit (loss)
2,975,000,000 JPY
5,827,000,000 JPY
5,569,000,000 JPY
3,960,000,000 JPY
Extraordinary income
1,979,000,000 JPY
0 JPY
Selling, general and administrative expenses
Advertising expenses
69,000,000 JPY
2,211,000,000 JPY
2,063,000,000 JPY
77,000,000 JPY
Remuneration for directors (and other officers)
263,000,000 JPY
266,000,000 JPY
Depreciation
250,000,000 JPY
243,000,000 JPY
Selling, general and administrative expenses
45,043,000,000 JPY
44,433,000,000 JPY
Extraordinary losses
0 JPY
900,000,000 JPY
352,000,000 JPY
0 JPY
Profit (loss) before income taxes
2,974,000,000 JPY
6,906,000,000 JPY
5,216,000,000 JPY
3,959,000,000 JPY
Operating profit (loss)
3,059,000,000 JPY
5,123,000,000 JPY
5,007,000,000 JPY
4,046,000,000 JPY
Non-operating income
Interest income
19,000,000 JPY
2,000,000 JPY
Dividend income
446,000,000 JPY
408,000,000 JPY
Share of profit of entities accounted for using equity method
JPY
25,000,000 JPY
Non-operating income
93,000,000 JPY
799,000,000 JPY
677,000,000 JPY
83,000,000 JPY
Income taxes - current
-25,000,000 JPY
2,462,000,000 JPY
1,630,000,000 JPY
45,000,000 JPY
Income taxes - deferred
-5,000,000 JPY
-279,000,000 JPY
-346,000,000 JPY
-5,000,000 JPY
Non-operating expenses
Interest expenses
66,000,000 JPY
66,000,000 JPY
Share of loss of entities accounted for using equity method
0 JPY
JPY
Non-operating expenses
177,000,000 JPY
94,000,000 JPY
115,000,000 JPY
170,000,000 JPY
Income taxes
-31,000,000 JPY
2,182,000,000 JPY
1,284,000,000 JPY
40,000,000 JPY
Profit (loss)
3,005,000,000 JPY
3,005,000,000 JPY
3,005,000,000 JPY
3,005,000,000 JPY
4,723,000,000 JPY
3,919,000,000 JPY
3,919,000,000 JPY
3,919,000,000 JPY
3,932,000,000 JPY
3,919,000,000 JPY
Extraordinary income
Gain on sale of non-current assets
10,000,000 JPY
0 JPY
Extraordinary losses
Impairment losses
257,000,000 JPY
JPY
Profit (loss) attributable to owners of parent
4,723,000,000 JPY
4,723,000,000 JPY
4,723,000,000 JPY
3,932,000,000 JPY
3,932,000,000 JPY
3,932,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
-578,000,000 JPY
-393,000,000 JPY
Foreign currency translation adjustment
229,000,000 JPY
151,000,000 JPY
Remeasurements of defined benefit plans, net of tax
-394,000,000 JPY
-86,000,000 JPY
Share of other comprehensive income of entities accounted for using equity method
5,000,000 JPY
21,000,000 JPY
Other comprehensive income
-737,000,000 JPY
-306,000,000 JPY
Comprehensive income
3,986,000,000 JPY
3,625,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
3,986,000,000 JPY
3,625,000,000 JPY
Comprehensive income attributable to non-controlling interests
JPY
JPY
Profit attributable to

Talk to a Data Expert

Have a question? We'll get back to you promptly.